日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition

局部高危前列腺癌中存在雄激素受体活性低的亚群,该亚群对HER2抑制剂敏感。

Scott Wilkinson ,Anson T Ku ,Rosina T Lis ,Isaiah M King ,Daniel Low ,Shana Y Trostel ,John R Bright ,Nicholas T Terrigino ,Anna Baj ,Emily R Summerbell ,Kayla E Heyward ,Sumeyra Kartal ,John M Fenimore ,Chennan Li ,Cassandra Singler ,BaoHan Vo ,Caroline S Jansen ,Huihui Ye ,Nichelle C Whitlock ,Stephanie A Harmon ,Nicole V Carrabba ,Rayann Atway ,Ross Lake ,David Y Takeda ,Haydn T Kissick ,Peter A Pinto ,Peter L Choyke ,Baris Turkbey ,William L Dahut ,Fatima Karzai ,Adam G Sowalsky

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

局限性高风险前列腺癌含有易受 HER2 抑制的雄激素受体低亚群

Scott Wilkinson, Anson T Ku, Rosina T Lis, Isaiah M King, Daniel Low, Shana Y Trostel, John R Bright, Nicholas T Terrigino, Anna Baj, John M Fenimore, Chennan Li, BaoHan Vo, Caroline S Jansen, Huihui Ye, Nichelle C Whitlock, Stephanie A Harmon, Nicole V Carrabba, Rayann Atway, Ross Lake, Haydn T Kis

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

新生前列腺癌的异质性推动了其进化和对强化激素疗法的抵抗

Scott Wilkinson, Huihui Ye, Fatima Karzai, Stephanie A Harmon, Nicholas T Terrigino, David J VanderWeele, John R Bright, Rayann Atway, Shana Y Trostel, Nicole V Carrabba, Nichelle C Whitlock, Stephanie M Walker, Rosina T Lis, Houssein Abdul Sater, Brian J Capaldo, Ravi A Madan, James L Gulley, Guine

A case report of multiple primary prostate tumors with differential drug sensitivity

一例具有不同药物敏感性的多个原发性前列腺肿瘤病例报告

Scott Wilkinson #, Stephanie A Harmon #, Nicholas T Terrigino, Fatima Karzai, Peter A Pinto, Ravi A Madan, David J VanderWeele, Ross Lake, Rayann Atway, John R Bright, Nicole V Carrabba, Shana Y Trostel, Rosina T Lis, Guinevere Chun, James L Gulley, Maria J Merino, Peter L Choyke, Huihui Ye, William